We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
-19.94%
1 Year Est. Return
+35.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$74M
AUM Growth
-$32.8M
Cap. Flow
-$14M
Cap. Flow %
-18.88%
Top 10 Hldgs %
57.13%
Holding
106
New
12
Increased
9
Reduced
42
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 21.3%
2 Financials 18.15%
3 Consumer Discretionary 9.23%
4 Communication Services 8.92%
5 Technology 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RESI
26
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$738K 1%
84,487
-52,157
-38% -$488K
SLV icon
27
iShares Silver Trust
SLV
$30.7B
$686K 0.93%
47,227
-26,508
-36% -$362K
ABT icon
28
Abbott
ABT
$187B
$662K 0.89%
9,158
-482
-5% -$33.9K
DB icon
29
Deutsche Bank
DB
$71.5B
$643K 0.87%
+78,908
New +$770K
CS
30
DELISTED
Credit Suisse Group
CS
$594K 0.8%
54,706
-38,260
-41% -$473K
AMRN
31
Amarin Corp
AMRN
$303M
$531K 0.72%
+1,951
New +$711K
ZGNX
32
DELISTED
Zogenix, Inc.
ZGNX
$427K 0.58%
11,704
-827
-7% -$33.9K
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$393K 0.53%
3,901
+1,395
+56% +$145K
BLUE
34
DELISTED
bluebird bio
BLUE
$387K 0.52%
301
-183
-38% -$281K
MRK icon
35
Merck
MRK
$318B
$372K 0.5%
5,108
-7,006
-58% -$495K
GWPH
36
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$371K 0.5%
3,813
-572
-13% -$75K
VWO icon
37
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$361K 0.49%
+9,480
New +$367K
IBB icon
38
iShares Biotechnology ETF
IBB
$9.77B
$359K 0.49%
3,722
-3,778
-50% -$401K
CCS icon
39
Century Communities
CCS
$2.03B
$348K 0.47%
+20,161
New +$420K
INCY icon
40
Incyte
INCY
$24.4B
$347K 0.47%
5,464
-3,309
-38% -$215K
BMRN icon
41
BioMarin Pharmaceuticals
BMRN
$12.4B
$332K 0.45%
3,902
-2,122
-35% -$202K
AERI
42
DELISTED
Aerie Pharmaceuticals
AERI
$326K 0.44%
9,021
-5,496
-38% -$258K
V icon
43
Visa
V
$677B
$323K 0.44%
2,450
-4,550
-65% -$628K
BCS icon
44
Barclays
BCS
$94.1B
$322K 0.44%
44,641
-114,548
-72% -$923K
TSRO
45
DELISTED
TESARO, Inc.
TSRO
$314K 0.42%
4,234
-5,790
-58% -$278K
NETI
46
DELISTED
Eneti Inc.
NETI
$293K 0.4%
5,697
-1,160
-17% -$66.2K
EIGI
47
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$277K 0.37%
41,587
-68,321
-62% -$566K
KPTI icon
48
Karyopharm Therapeutics
KPTI
$48M
$249K 0.34%
1,769
+600
+51% +$101K
WMB icon
49
Williams Companies
WMB
$86.1B
$242K 0.33%
+10,967
New +$274K
GM.WS.B
50
DELISTED
General Motors Company
GM.WS.B
$229K 0.31%
14,403
-758
-5% -$12.9K

Similar funds

Kazazian Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Kazazian Asset Management held 106 positions worth $74M, down 31% from $107M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Kazazian Asset Management withdrew a net $14M in Q4 2018, closing 42 positions and reducing 42 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kazazian Asset Management opened a new position in iShares Russell 2000 ETF worth $6.64M.

  • Kazazian Asset Management's largest Q4 2018 buy was iShares Russell 2000 ETF: 49,629 shares worth $6.64M.
  • Kazazian Asset Management added most to Apple in Q4 2018, an estimated $3.22M increase.
  • Kazazian Asset Management's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $8.03M.
  • Kazazian Asset Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2018, selling an estimated $1.6M.
  • Kazazian Asset Management's ten largest holdings make up 57% of its $74M portfolio in Q4 2018.
  • Kazazian Asset Management opened 12 new positions and closed 42 in Q4 2018.
  • Kazazian Asset Management's portfolio value fell 31% quarter-over-quarter to $74M.

Based on Kazazian Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.